Study detail
RecruitingPhase 1
The Role of Bimatoprost in Graves' Periorbitopathy
Johns Hopkins University
Summary
Testing whether Bimatoprost, a topical eye drop used for glaucoma, can be used to induce periorbital fat atrophy in patients with Graves' disease
Eligibility
- Age range
- 18+ years
- Sex
- All
- Healthy volunteers
- No
Detailed criteria
Inclusion Criteria: Graves' Ophthalmopathy with Exophthalmos/Proptosis - Exclusion Criteria: Active Graves Disease, Currently pregnant, Taking Steroids \-
Interventions
- DrugBimatoprost Ophthalmic
Bimatoprost, aka Lumigan, one drop in one eye nightly
Location
- University of WashingtonSeattle, Washington